<DOC>
	<DOCNO>NCT02181842</DOCNO>
	<brief_summary>The purpose survey evaluate effect glycemic control evaluate safety long-term use pioglitazone tablet ( Actos Tablets ) type 2 diabetic patient inadequate glycemic control prior history cerebral infarction .</brief_summary>
	<brief_title>Pioglitazone Tablets Specified Drug-use Survey &lt; Survey Glycemic Control Type 2 Diabetic Patients With History Cerebral Infarction &gt;</brief_title>
	<detailed_description>This survey design evaluate effect glycemic control evaluate safety long-term use pioglitazone tablet ( Actos Tablets ) type 2 diabetic patient inadequate glycemic control prior history cerebral infarction . For adult , 15-30 mg pioglitazone usually administer orally daily breakfast . The dose adjust depend sex , age , symptom ; however , maximum daily dose exceed 45 mg .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Type 2 diabetic patient prior history cerebral infarction meet following condition , [ 1 ] [ 3 ] , time enrollment survey : 1 . First onset cerebral infarction least 24 week prior enrollment 2 . HbA1c value ≥ 6.5 % within 12 week prior start treatment Actos Tablets 3 . No prior history treatment Actos Tablets since first onset cerebral infarction Patients meet follow condition , [ 1 ] [ 5 ] , shall exclude survey : 1 . Contraindication Actos Tablets 2 . Prior history recurrence cerebral infarction 3 . Prior history cerebral hemorrhage subarachnoid hemorrhage 4 . Complications prior history myocardial infarction , angina pectoris , cardiomyopathy , hypertensive heart disease , atrial fibrillation , atrial flutter , valvular disease 5 . Reduced cardiac function ( define ejection fraction [ EF ] ≤ 40 % )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Pharmacological therapy</keyword>
</DOC>